Jun kinase modulates tumor necrosis factor-dependent apoptosis in liver cells

Hepatology

Volumn 36, Issue 2, 2002, Pages 315-325

  Liedtke, Christian ^a   Plümpe, Jörg ^a   Kubicka, Stefan ^a   Bradham, Cynthia A ^b   Manns, Michael P ^a   Brenner, David A ^b   Trautwein, Christian ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

^b UNIVERSITY OF NORTH CAROLINA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOVIRUS VECTOR; CYCLOHEXIMIDE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE 1; PROTEIN BCL 2; PROTEIN TRADD; STRESS ACTIVATED PROTEIN KINASE; TUMOR NECROSIS FACTOR; TUMOR NECROSIS FACTOR RECEPTOR; TUMOR NECROSIS FACTOR RECEPTOR 1; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; CELL DEATH; ENZYME ACTIVATION; ENZYME INHIBITION; GENETIC TRANSCRIPTION; HEPATOMA CELL; HUMAN; HUMAN CELL; LIVER CELL; MEMBRANE PERMEABILITY; MITOCHONDRION; NONHUMAN; PRIORITY JOURNAL; PROTEIN DOMAIN;

EID: 0036329891     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1053/jhep.2002.34615     Document Type: Article

References (48)

1. Role of tumor necrosis factor-α in the pathophysiologic alterations after hepatic ischemia/reperfusion injury in the rat
2. Enhanced tumour necrosis factor and interleukin-1 in fulminant hepatic failure
3. Increased plasma tumor necrosis factor in severe alcoholic hepatitis
4. Tumor necrosis factor receptor and Fas signaling mechanisms
5. Mechanisms of hepatic toxicity. I. TNF induced liver injury
6. Two CD95 (APO-1/Fas) signaling pathways
7. The mitochondrial permeability transition is required for tumor necrosis factor alpha-mediated apoptosis and cytochrome c release
8. Tumor necrosis factor α in the pathogenesis of human and murine fulminant hepatic failure
9. Bid-deficient mice are resistant to Fas-induced hepatocellular apoptosis
10. Embryonic lethality and liver degeneration in mice lacking the RelA component of NF-kappa B
11. Absence of tumor necrosis factor rescues RelA-deficient mice from embryonic lethality
12. NFκB prevents apoptosis and liver dysfunction during liver regeneration
13. NF-κB determines between apoptosis and proliferation in hepatocytes during liver regeneration
14. Activation of the c-Jun N-terminal kinase/stress-activated protein kinase pathway by overexpression of caspase-8 and ist homologs
15. Concanavalin A-induced liver cell damage: Activation of intracellular pathways triggered by tumor necrosis factor in mice
16. Dissection of the intracellular pathways in hepatocytes reveals a direct role of Jun kinase and IRF-1 in con A-induced liver failure
17. Reperfusion after liver transplantation in rats differentially activates the mitogen-activated protein kinases
18. Gene delivery of Cu/Zn-superoxide dismutase improves graft function after transplantation of fatty livers in the rat
19. CREB controls LAP/C/EBP beta transcription
20. The designer cytokine hyper-interleukin-6 is a potent activator of STAT3-dependent gene transcription in vivo and in vitro
21. A rapid and simple method for measuring thymocyte apoptosis by propidium iodide staining and flow cytometry
22. The mitochondrial permeability transition augments Fas-induced apoptosis in mouse hepatocytes
23. Dominant-negative TAK1 induces c-Myc and G(0) exit in liver
24. JNF-κB inactivation converts a hepatocyte cell line TNF-alpha response from proliferation to apoptosis
25. Quinone reductase inhibitors block SAPK/JNK and NFκB pathways and potentiate apoptosis
26. NF-κB induces expression of the Bcl-2 homologue A1/Bfl-1 to preferentially suppress chemotherapy-induced apoptosis
27. Identification of a member of the MAPKKK family as a potential mediator of TGF-β signal transduction
28. Activation of the hematopoietic progenitor kinase-1 (HPK1)-dependent, stress-activated c-Jun N-terminal kinase (JNK) pathway by transforming growth factor beta (TGF-β)-activated kinase (TAK1), a kinase mediator of TGF β signal transduction
29. Bcl-2 and mitochondrial oxygen radicals. New approaches with reactive oxygen
30. Bcl-2 inhibits the mitochondrial release of an apoptogenic protease
31. TNF receptor-associated factor-2 is involved in both IL-1 β and TNF-α signaling cascades leading to NF-κB activation and IL-8 expression in human intestinal epithelial cells
32. The kinase TAK1 can activate the NIK-I κB as well as the MAP kinase cascade in the IL-1 signalling pathway
33. TAB2, a novel adaptor protein, mediates activation of TAK1 MAPKKK by linking TAK1 to TRAF6 in the IL-1 signal transduction pathway
34. SP600125, an anrhrapyrazolone inhibitor of Jun N-terminal kinase
35. Metabolic depletion of ATP by fructose inversely controls CD95- and tumor necrosis factor receptor 1-mediated hepatic apoptosis
36. Amino-terminal phosphorylation of c-Jun regulates stress-induced apoptosis and cellular proliferation
37. MEKK1 suppresses oxidative stress-induced apoptosis of embryonic stem cell-derived cardiac myocytes
38. Early activation of c-Jun N-terminal kinase and p38 kinase regulate cell survival in response to tumor necrosis factor α
39. Induction of gadd45β by NF-κB downregulates pro-apoptotic JNK signalling
40. Inhibition of JNK activation through NF-κB target genes
41. Selective repopulation of normal mouse liver by Fas/CD95-resistant hepatocytes
42. Requirement for ceramide-initiated SAPK/JNK signalling in stress-induced apoptosis
43. Phosphorylation of FADD/MORT1 at serine 194 and association with a 70-kDa cell cycle-regulated protein kinase
44. Phosphatase inhibition promotes antiapoptotic but not proliferative signaling pathways in erythropoietin-dependent HCD57 cells
45. Deletion of the loop region of Bcl-2 completely blocks paclitaxel-induced apoptosis
46. Vinblastine-induced phosphorylation of Bcl-2 and Bcl-XL is mediated by JNK and occurs in parallel with inactivation of the raf-1/MEK/ ERK cascade
47. Immunohistochemical evaluation of Bcl-2 gene family expression in liver of hepatitis C and cirrhotic patients: A novel mechanism to explain the high incidence of hepatocarcinoma in cirrhotics
48. Expression of Bcl-2 family during liver regeneration and identification of Bcl-x as a delayed early response gene